C. Hulin

400 total citations
16 papers, 188 citations indexed

About

C. Hulin is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, C. Hulin has authored 16 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in C. Hulin's work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (2 papers). C. Hulin is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (2 papers). C. Hulin collaborates with scholars based in France, United States and Czechia. C. Hulin's co-authors include Hervé Avet‐Loiseau, Philippe Moreau, Thierry Façon, Laurent Garderet, Philippe Casassus, Laurent Voillat, Stéphane Minvielle, Wilfried Gouraud, Edouard Randriamalala and Pascal Godmer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

C. Hulin

14 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Hulin France 6 161 141 92 20 19 16 188
Petra H.M. Westveer Netherlands 6 198 1.2× 144 1.0× 92 1.0× 19 0.9× 7 0.4× 8 212
Ravi Vij United States 4 137 0.9× 117 0.8× 60 0.7× 11 0.6× 5 0.3× 13 171
R. Alexanian United States 6 177 1.1× 125 0.9× 96 1.0× 12 0.6× 7 0.4× 12 195
Ana-Isabel Teruel Spain 3 175 1.1× 140 1.0× 84 0.9× 26 1.3× 4 0.2× 3 181
Eli Gabayan United States 4 295 1.8× 269 1.9× 188 2.0× 21 1.1× 6 0.3× 6 343
Christopher Maisel United States 7 89 0.6× 79 0.6× 53 0.6× 15 0.8× 8 0.4× 20 127
Laure Buisson France 4 176 1.1× 142 1.0× 64 0.7× 19 0.9× 40 2.1× 5 191
Rafael Martínez-Martinez Mexico 4 191 1.2× 181 1.3× 118 1.3× 14 0.7× 12 0.6× 6 236
Laura Rosiñol Spain 5 152 0.9× 94 0.7× 89 1.0× 29 1.4× 4 0.2× 18 159
Olga Samoilova United States 2 296 1.8× 250 1.8× 192 2.1× 30 1.5× 3 0.2× 2 313

Countries citing papers authored by C. Hulin

Since Specialization
Citations

This map shows the geographic impact of C. Hulin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Hulin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Hulin more than expected).

Fields of papers citing papers by C. Hulin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Hulin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Hulin. The network helps show where C. Hulin may publish in the future.

Co-authorship network of co-authors of C. Hulin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Hulin. A scholar is included among the top collaborators of C. Hulin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Hulin. C. Hulin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tinquaut, Fabien, Bernard Tardy, Philippe Moreau, et al.. (2021). PO-82 Impede VTE vs saved scores to predict the risk of venous thromboembolism in newly diagnosed multiple myeloma with immunomodulatory drugs: how to choose?. Thrombosis Research. 200. S61–S62. 1 indexed citations
2.
Corso, Alessandro, Michel Delforge, Kevin Song, et al.. (2015). HEALTH RESOURCE UTILIZATION WITH CONTINUOUS LENALIDOMIDE TREATMENT (TX) IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM). Haematologica. 100. 24–25. 1 indexed citations
3.
Ladrière, Marc, et al.. (2014). A de novo monoclonal immunoglobulin deposition disease in a kidney transplant recipient: a case report. Journal of Medical Case Reports. 8(1). 205–205. 1 indexed citations
4.
Magrangeas, Florence, Hervé Avet‐Loiseau, Wilfried Gouraud, et al.. (2012). Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 27(2). 473–481. 83 indexed citations
5.
Kropff, Martin, Jens Hillengaß, Tadeusz Robak, et al.. (2011). Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trial. Haematologica. 97(5). 784–791. 43 indexed citations
6.
Delforge, Michel, Ravinder Dhawan, Konstantinos Zervas, et al.. (2009). A134 Peripheral Neuropathy as Assessed in an International Observational Study of Bortezomib. Clinical Lymphoma & Myeloma. 9. S21–S22.
7.
8.
Avet‐Loiseau, Hervé, Jean Soulier, Jean‐Paul Fermand, et al.. (2008). Impact of Chromosomal Abnormalities Del(13), T(4;14), and Del(17p) and Prior Treatment on Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Treated with Lenalidomide. Blood. 112(11). 3685–3685. 9 indexed citations
9.
Armoiry, Xavier, Francis Fagnani, Lotfi Benboubker, et al.. (2008). Estimating direct costs of care for patients with relapsed or refractory multiple myeloma in french hospitals. Journal of Clinical Oncology. 26(15_suppl). 8596–8596. 2 indexed citations
10.
Moreau, Philippe, Valérie Coiteux, C. Hulin, et al.. (2007). Prospective comparison of subcutaneous to intravenous administration of bortezomib in patients with multiple myeloma: Pharmacokinetics, efficacy and toxicity. Journal of Clinical Oncology. 25(18_suppl). 8046–8046. 1 indexed citations
11.
12.
Hulin, C., et al.. (2004). Gale profuse chez un patient en GVH chronique : difficultés diagnostiques et conséquences. Médecine et Maladies Infectieuses. 34(10). 485–487. 1 indexed citations
13.
14.
Leonard, Sean, C. Hulin, René Anxionnat, et al.. (2002). [Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia].. PubMed. 158(11). 1121–3. 8 indexed citations
15.
Lesesve, Jean‐François, Christine Jacob, Véronique Latger‐Cannard, et al.. (2001). [Diagnosis of lymphoid hemopathy at the time of the diagnosis of cryoglobulinemia].. PubMed. 59(1). 84–9.
16.
Hulin, C., et al.. (1999). Des leucocytes chevelus et fébriles. La Revue de Médecine Interne. 20. 313s–314s. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petra H.M. Westveer Breakdown of academic impact, for papers by Ravi Vij Breakdown of academic impact, for papers by R. Alexanian Breakdown of academic impact, for papers by Ana-Isabel Teruel Breakdown of academic impact, for papers by Eli Gabayan Breakdown of academic impact, for papers by Christopher Maisel Breakdown of academic impact, for papers by Laure Buisson Breakdown of academic impact, for papers by Rafael Martínez-Martinez Breakdown of academic impact, for papers by Laura Rosiñol Breakdown of academic impact, for papers by Olga Samoilova
Rankless by CCL
2026